The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists

Tamotsu Tsukahara1

  • 1Department of Integrative Physiology and Bio-System Control, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.

PPAR Research
|June 14, 2012
PubMed

Insights

2,3-cyclic phosphatidic acid (cPA) inhibits cancer progression by negatively regulating peroxisome proliferator-activated receptor gamma (PPARγ). This novel lipid ligand stabilizes corepressor binding, repressing PPARγ transcriptional activity and preventing disease-related processes.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Peroxisome proliferator-activated receptor gamma (PPARγ) is a therapeutic target for type II diabetes and has potential in treating atherosclerosis, obesity, and cancers.
  • 2,3-cyclic phosphatidic acid (cPA), an endogenous PPARγ antagonist, inhibits cancer cell invasion and metastasis.
  • cPA shares structural similarities with lysophosphatidic acid (LPA).

Purpose of the Study:

  • To elucidate the molecular mechanism by which cPA regulates PPARγ function.
  • To summarize current knowledge on PPARγ-mediated transcriptional activity and repression by lipid-derived ligands like cPA.

Main Methods:

  • Investigated the interaction between cPA, PPARγ, and corepressor proteins.
  • Analyzed the effects of cPA on PPARγ target gene transcription.
  • Examined cPA's impact on cellular processes regulated by PPARγ.

Main Results:

  • cPA negatively regulates PPARγ activity by stabilizing the binding of the silencing mediator of retinoic acid and thyroid hormone receptor corepressor.
  • cPA prevents neointima formation, adipocyte differentiation, and lipid accumulation.
  • cPA inhibits the upregulation of PPARγ target gene transcription.

Conclusions:

  • cPA acts as a novel PPARγ antagonist, offering therapeutic potential beyond cancer, including in metabolic and cardiovascular diseases.
  • Understanding cPA's mechanism of action provides insights into regulating PPARγ transcriptional activity.
  • cPA represents a promising therapeutic strategy for diseases involving PPARγ dysregulation.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...